참고문헌 (59)

1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders , 5th edn . American Psychiatric Publishing , Arlington, WA , 2013 . 

2. Tandon R , Gaebel W , Barch DM et al . Definition and description of schizophrenia in the DSM‐5 . Schizophr. Res. 2013 ; 150 : 3 – 10 . 

   상세보기

3. Gaebel W , Zielasek J , Cleveland HR . Classifying psychosis – challenges and opportunities . Int. Rev. Psychiatry 2012 ; 24 : 538 – 548 . 

4. Gaebel W , Zielasek J , Cleveland HR . Psychotic disorders in ICD‐11 . Asian J. Psychiatr. 2013 ; 6 : 263 – 265 . 

   상세보기

5. Nordgaard J , Arnfred SM , Handest P , Parnas J . The diagnostic status of first‐rank symptoms . Schizophr. Bull. 2008 ; 34 : 137 – 154 . 

   상세보기

6. Wilson JE , Niu K , Nicolson SE , Levine SZ , Heckers S . The diagnostic criteria and structure of catatonia . Schizophr. Res. 2015 ; 164 : 256 – 262 . 

   상세보기

7. Tsuang MT , Van Os J , Tandon R et al . Attenuated psychosis syndrome in DSM‐5 . Schizophr. Res. 2013 ; 150 : 31 – 35 . 

   상세보기

8. Schultze‐Lutter F , Michel C , Ruhrmann S , Schimmelmann BG . Prevalence and clinical significance of DSM‐5‐attenuated psychosis syndrome in adolescents and young adults in the general population: The Bern Epidemiological At‐Risk (BEAR) study . Schizophr. Bull. 2014 ; 40 : 1499 – 1508 . 

   상세보기

9. Chen C , Cheng L , Grennan K et al . Two gene co‐expression modules differentiate psychotics and controls . Mol. Psychiatry 2013 ; 18 : 1308 – 1314 . 

   상세보기

10. Hiroi N , Takahashi T , Hishimoto A , Izumi T , Boku S , Hiramoto T . Copy number variation at 22q11.2: From rare variants to common mechanisms of developmental neuropsychiatric disorders . Mol. Psychiatry 2013 ; 18 : 1153 – 1165 . 

    상세보기

11. Ripke S , O'Dushlaine C , Chambert K et al . Genome‐wide association analysis identifies 13 new risk loci for schizophrenia . Nat. Genet. 2013 ; 45 : 1150 – 1159 . 

    상세보기

12. Schwab SG , Wildenauer DB . Genetics of psychiatric disorders in the GWAS era: An update on schizophrenia . Eur. Arch. Psychiatry Clin. Neurosci. 2013 ; 263 ( Suppl. 2 ): S147 – S154 . 

13. Xu B , Ionita‐Laza I , Roos JL et al . De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia . Nat. Genet. 2012 ; 44 : 1365 – 1369 . 

    상세보기

14. Deakin J , Lennox BR , Zandi MS . Antibodies to the N‐methyl‐D‐aspartate receptor and other synaptic proteins in psychosis . Biol. Psychiatry 2014 ; 75 : 284 – 291 . 

    상세보기

15. Needham E , Zandi MS . Recent advances in the neuroimmunology of cell‐surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia . J. Neurol. 2014 ; 261 : 2037 – 2042 . 

    상세보기

16. Zandi MS , Deakin JB , Morris K et al . Immunotherapy for patients with acute psychosis and serum N‐Methyl D‐Aspartate receptor (NMDAR) antibodies: A description of a treated case series . Schizophr. Res. 2014 ; 160 : 193 – 195 . 

    상세보기

17. Howes OD , Kapur S . A neurobiological hypothesis for the classification of schizophrenia: Type A (hyperdopaminergic) and type B (normodopaminergic) . Br. J. Psychiatry 2014 ; 205 : 1 – 3 . 

    상세보기

18. Wijtenburg SA , Yang S , Fischer BA , Rowland LM . In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: Application to schizophrenia . Neurosci. Biobehav. Rev. 2015 ; 51C : 276 – 295 . 

19. Deco G , Kringelbach ML . Great expectations: Using whole‐brain computational connectomics for understanding neuropsychiatric disorders . Neuron 2014 ; 84 : 892 – 905 . 

    상세보기

20. Zielasek J , Gaebel W . Modern modularity and the road towards a modular psychiatry . Eur. Arch. Psychiatry Clin. Neurosci. 2008 ; 258 ( Suppl. 5 ): 60 – 65 . 

21. Fornito A , Zalesky A , Breakspear M . The connectomics of brain disorders . Nat. Rev. Neurosci. 2015 ; 16 : 159 – 172 . 

    상세보기

22. Winton‐Brown TT , Fusar‐Poli P , Ungless MA , Howes OD . Dopaminergic basis of salience dysregulation in psychosis . Trends Neurosci. 2014 ; 37 : 85 – 94 . 

    상세보기

23. Garety PA , Freeman D . The past and future of delusions research: From the inexplicable to the treatable . Br. J. Psychiatry 2013 ; 203 : 327 – 333 . 

    상세보기

24. Eifler S , Rausch F , Schirmbeck F et al . Neurocognitive capabilities modulate the integration of evidence in schizophrenia . Psychiatry Res. 2014 ; 219 : 72 – 78 . 

    상세보기

25. Castellani CA , Melka MG , Diehl EJ , Laufer BI , O'Reilly RL , Singh SM . DNA methylation in psychosis: Insights into aetiology and treatment . Epigenomics 2015 ; 7 : 67 – 74 . 

26. Akdeniz C , Tost H , Meyer‐Lindenberg A . The neurobiology of social environmental risk for schizophrenia: An evolving research field . Soc. Psychiatry Psychiatr. Epidemiol. 2014 ; 49 : 507 – 517 . 

    상세보기

27. Haddad L , Schäfer A , Streit F et al . Brain structure correlates of urban upbringing, an environmental risk factor for schizophrenia . Schizophr. Bull. 2015 ; 41 : 115 – 122 . 

    상세보기

28. Allardyce J , Gaebel W , Zielasek J , van Os J . Deconstructing Psychosis conference February 2006: The validity of schizophrenia and alternative approaches to the classification of psychosis . Schizophr. Bull. 2007 ; 33 : 863 – 867 . 

    상세보기

29. Braff DL , Freedman R , Schork NJ , Gottesman II . Deconstructing schizophrenia: An overview of the use of endophenotypes in order to understand a complex disorder . Schizophr. Bull. 2007 ; 33 : 21 – 32 . 

    상세보기

30. Pickard BS . Schizophrenia biomarkers: Translating the descriptive into the diagnostic . J. Psychopharmacol. 2015 ; 29 : 138 – 143 . 

    상세보기

31. Morris SE , Cuthbert BN . Research Domain Criteria: Cognitive systems, neural circuits, and dimensions of behavior . Dialogues Clin. Neurosci. 2012 ; 14 : 29 – 37 . 

32. Badcock JC , Hugdahl K . A synthesis of evidence on inhibitory control and auditory hallucinations based on the Research Domain Criteria (RDoC) framework . Front. Hum. Neurosci. 2014 ; 8 : 180 . 

33. Ford JM , Morris SE , Hoffman RE et al . Studying hallucinations within the NIMH RDoC framework . Schizophr. Bull. 2014 ; 40 ( Suppl. 4 ): S295 – S304 . 

34. Owen MJ . New approaches to psychiatric diagnostic classification . Neuron 2014 ; 84 : 564 – 571 . 

    상세보기

35. Saha S , Chant D , McGrath J . A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Arch. Gen. Psychiatry 2007 ; 64 : 1123 – 1131 . 

36. Anthes E . Live faster, die younger . Nature 2014 ; 508 : S16 – S17 . 

37. Cullen BA , McGinty EE , Zhang Y et al . Guideline‐concordant antipsychotic use and mortality in schizophrenia . Schizophr. Bull. 2013 ; 39 : 1159 – 1168 . 

    상세보기

38. Sarin F , Wallin L . Cognitive model and cognitive behavior therapy for schizophrenia: An overview . Nord. J. Psychiatry 2014 ; 68 : 145 – 153 . 

39. Dunlop J , Brandon NJ . Schizophrenia drug discovery and development in an evolving era: Are new drug targets fulfilling expectations? J. Psychopharmacol. 2015 ; 29 : 230 – 238 . 

    상세보기

40. Choi DW , Armitage R , Brady LS et al . Medicines for the mind: Policy‐based ‘pull’ incentives for creating breakthrough CNS drugs . Neuron 2014 ; 84 : 554 – 563 . 

    상세보기

41. Pankevich DE , Altevogt BM , Dunlop J , Gage FH , Hyman SE . Improving and accelerating drug development for nervous system disorders . Neuron 2014 ; 84 : 546 – 553 . 

    상세보기

42. Huhn M , Tardy M , Spineli LM et al . Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: A systematic overview of meta‐analyses . JAMA Psychiatry 2014 ; 71 : 706 – 715 . 

    상세보기

43. Thomas N , Hayward M , Peters E et al . Psychological therapies for auditory hallucinations (voices): Current status and key directions for future research . Schizophr. Bull. 2014 ; 40 ( Suppl. 4 ): S202 – S212 . 

44. Drusch K , Stroth S , Kamp D , Frommann N , Wölwer W . Effects of Training of Affect Recognition on the recognition and visual exploration of emotional faces in schizophrenia . Schizophr. Res. 2014 ; 159 : 485 – 490 . 

    상세보기

45. Hovington CL , McGirr A , Lepage M , Berlim MT . Repetitive transcranial magnetic stimulation (rTMS) for treating major depression and schizophrenia: A systematic review of recent meta‐analyses . Ann. Med. 2013 ; 45 : 308 – 321 . 

    상세보기

46. Wobrock T , Guse B , Cordes J et al . Left prefrontal high‐frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: A sham‐controlled, randomized multicenter trial . Biol. Psychiatry 2015 ; 77 : 978 – 988 . 

47. Wölwer W , Lowe A , Brinkmeyer J et al . Repetitive transcranial magnetic stimulation (rTMS) improves facial affect recognition in schizophrenia . Brain Stimul. 2014 ; 7 : 559 – 563 . 

48. Slotema CW , Blom JD , van Lutterveld R , Hoek HW , Sommer IE . Review of the efficacy of transcranial magnetic stimulation for auditory verbal hallucinations . Biol. Psychiatry 2014 ; 76 : 101 – 110 . 

    상세보기

49. Gaebel W , Muijen M , Baumann AE et al . EPA guidance on building trust in mental health services . Eur. Psychiatry 2014 ; 29 : 83 – 100 . 

50. Gaebel W , Zielasek J . Overcoming stigmatizing attitudes towards psychiatrists and psychiatry . Acta Psychiatr. Scand. 2015 ; 131 : 5 – 7 . 

    상세보기

51. Gaebel W , Riesbeck M , Wobrock T . Schizophrenia guidelines across the world: A selective review and comparison . Int. Rev. Psychiatry 2011 ; 23 : 379 – 387 . 

52. Miller AL , Crismon ML , Rush AJ et al . The Texas medication algorithm project: Clinical results for schizophrenia . Schizophr. Bull. 2004 ; 30 : 627 – 647 . 

    상세보기

53. Weinmann S , Hoerger S , Erath M , Kilian R , Gaebel W , Becker T . Implementation of a schizophrenia practice guideline: Clinical results . J. Clin. Psychiatry 2008 ; 69 : 1299 – 1306 . 

    상세보기

54. Kohn R , Saxena S , Levav I , Saraceno B . The treatment gap in mental health care . Bull. WHO 2004 ; 82 : 858 – 866 . 

    상세보기

55. Barker‐Haliski M , Friedman D , White HS , French JA . How clinical development can, and should, inform translational science . Neuron 2014 ; 84 : 582 – 593 . 

    상세보기

56. Koutsouleris N , Riecher‐Rössler A et al . Detecting the psychosis prodrome across high‐risk populations using neuroanatomical biomarkers . Schizophr. Bull. 2015 ; 41 : 471 – 482 . 

    상세보기

57. Kahn RS , Sommer IE . The neurobiology and treatment of first‐episode schizophrenia . Mol. Psychiatry 2015 ; 20 : 84 – 97 . 

    상세보기

58. Krystal JH , State MW . Psychiatric disorders: Diagnosis to therapy . Cell 2014 ; 157 : 201 – 214 . 

    상세보기

59. Schubert CR , Xi HS , Wendland JR , O'Donnell P . Translating human genetics into novel treatment targets for schizophrenia . Neuron 2014 ; 84 : 537 – 541 . 

    상세보기